Biolidics Limited designs and manufactures medical devices. The Company specializes in providing medical applications and equipment for tumor diagnosis and cancer treatment. Biolidics offers cell enrichment systems. Biolidics serves patients worldwide.

General Announcement: ACHIEVEMENT OF THE NPAT TARGET AND THE RELEASE OF THE EARN-OUT CONSIDERATION SHARES HELD IN ESCROW

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Cessation as a substantial shareholder - Wu Kun Wei

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of interest / Changes in interest of substantial shareholder - Wu Kun Wei

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): NOTIFICATION IN RESPECT OF CESSATION AS SUBSTANTIAL SHAREHOLDER - YUAN ZHI  JUN

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00